» Articles » PMID: 29992497

MeCP2 Differentially Regulate the Myelin MBP and PLP Protein Expression in Oligodendrocytes and C6 Glioma

Overview
Journal J Mol Neurosci
Date 2018 Jul 12
PMID 29992497
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

MeCP2 (methyl-CpG binding protein 2), an epigenetic regulator, has been shown to regulate the function of neurons and glial cells. Our previous study has demonstrated that MeCP2 repress the myelin gene expression in rat oligodendrocytes but whether MeCP2 bind to myelin gene MBP and PLP is not yet known. Besides oligodendrocytes, C6 glioma also expresses myelin genes and could be used as a model system to study myelin gene expression. In the present study, we determined that MeCP2 directly bind to MBP, PLP, and BDNF promoter in oligodendrocytes. Further, it was found that MeCP2 differentially regulates the myelin gene expression in oligodendrocytes and C6 glioma. In contrast to oligodendrocytes, MeCP2 does not bind to promoter region of MBP and PLP in C6 glioma suggest that MeCP2 differentially regulates the gene expression in different cell types.

Citing Articles

Epigenetics in rare neurological diseases.

Roberts C, Arezoumand K, Kadar Shahib A, Davie J, Rastegar M Front Cell Dev Biol. 2024; 12:1413248.

PMID: 39108836 PMC: 11300358. DOI: 10.3389/fcell.2024.1413248.


Evaluating Gene Expression and Methylation Profiles of TCF4, MBP, and EGR1 in Peripheral Blood of Drug-Free Patients with Schizophrenia: Correlations with Psychopathology, Intelligence, and Cognitive Impairment.

Yazarlou F, Tabibian M, Azarnezhad A, Sadeghi Rad H, Lipovich L, Sanati G J Mol Neurosci. 2023; 73(9-10):738-750.

PMID: 37668894 DOI: 10.1007/s12031-023-02150-x.


Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Horjus J, van Mourik-Banda T, Heerings M, Hakobjan M, De Witte W, Heersema D Int J Mol Sci. 2022; 23(19).

PMID: 36232761 PMC: 9570223. DOI: 10.3390/ijms231911461.


Advances in the pathogenesis of Rett syndrome using cell models.

Lu S, Chen Y, Wang Z Animal Model Exp Med. 2022; 5(6):532-541.

PMID: 35785421 PMC: 9773312. DOI: 10.1002/ame2.12236.


MeCP2 Epigenetic Silencing of Gene in Primary Sensory Neurons Under Neuropathic Pain Conditions.

Sun N, Yu L, Gao Y, Ma L, Ren J, Liu Y Front Neurosci. 2021; 15:743207.

PMID: 34803588 PMC: 8602696. DOI: 10.3389/fnins.2021.743207.

References
1.
Ueno T, Ito J, Hoshikawa S, Ohori Y, Fujiwara S, Yamamoto S . The identification of transcriptional targets of Ascl1 in oligodendrocyte development. Glia. 2012; 60(10):1495-505. DOI: 10.1002/glia.22369. View

2.
Leisewitz A, Urrutia C, Martinez G, Loyola G, Bronfman M . A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis. J Cell Physiol. 2008; 217(2):367-76. DOI: 10.1002/jcp.21509. View

3.
Urdinguio R, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez A . Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One. 2008; 3(11):e3669. PMC: 2576441. DOI: 10.1371/journal.pone.0003669. View

4.
Sharma K, Singh J, Frost E, Pillai P . MeCP2 in central nervous system glial cells: current updates. Acta Neurobiol Exp (Wars). 2018; 78(1):30-40. View

5.
Swiss V, Nguyen T, Dugas J, Ibrahim A, Barres B, Androulakis I . Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PLoS One. 2011; 6(4):e18088. PMC: 3072388. DOI: 10.1371/journal.pone.0018088. View